Enhancing Evidence Management: DistillerSR and CCC Alliance

Enhancing Evidence Management: DistillerSR and CCC Alliance
DistillerSR customers can now search for and purchase content directly from CCC's proprietary bibliographic database of more than 165 million articles.
DistillerSR Inc., the leading provider of literature review automation software, has made a significant advancement by partnering with CCC to enable users to order and access scholarly journal articles through the RightFind Enterprise platform. This strategic collaboration aims to streamline the process, allowing users to integrate content procurement directly within their existing workflows.
Integration Benefits for Users
The integration with RightFind Enterprise simplifies the tasks associated with obtaining non-subscribed scientific literature. By eliminating the need for systematic review teams to navigate multiple systems and websites, it enhances efficiency and saves valuable time. Users can swiftly order, pay for, and consolidate payment records, all from a single platform.
Co-Presentation at the Evidence Matters Summit
Both companies are set to co-present this integration at the Evidence Matters Summit, showcasing its capabilities to the user community and highlighting how it optimizes the literature review process.
Streamlined Access to Relevant Research
Peter O'Blenis, CEO of DistillerSR, expressed the company's enthusiasm about this partnership, emphasizing that timely access to RightFind content will significantly reduce the time needed to process literature and synthesize evidence for reviews. This effort aims to lower review costs and expedite the development of medical products and healthcare guidelines.
Key Features of RightFind Enterprise
RightFind Enterprise serves as a part of CCC's RightFind Suite, a robust suite of integrated software modules that empowers professionals in R&D-focused companies to manage, share, and analyze content. This integration takes advantage of the existing collaboration between RightFind and DistillerSR, enabling users to efficiently retrieve bibliographic content while leveraging DistillerSR’s validated workflow, which can decrease literature review timelines by up to 70%.
Expert Insights on Current Research Needs
The importance of accessing reputable and trustworthy information is underscored by Lauren Tulloch, Vice President and Managing Director at CCC. She notes that the expanded integration of RightFind Enterprise with DistillerSR is vital for helping researchers secure the necessary information and accelerate their innovation processes.
CCC plays a crucial role in assisting organizations in managing extensive amounts of published and proprietary data. Their expertise in sourcing data from diverse industries benefits numerous companies, enhancing content discoverability and processing capabilities.
About DistillerSR's Evidence Management Platform
DistillerSR’s evidence management platform is designed to facilitate the automated collection, reuse, and analysis of literature research, offering a fast, accurate, and transparent approach at scale. Since its inception in 2016, DistillerSR has become a trusted name among over 260 leading research organizations worldwide, including major pharmaceutical and medical device companies.
The Future of Research and Evidence Gathering
As healthcare researchers increasingly rely on DistillerSR to automate their literature review processes, they can make better-informing decisions regarding health policy, clinical guidelines, and regulatory submissions. This not only enhances their overall research but improves the pace of innovation in the medical field.
About DistillerSR Inc.
For information and further details, visit www.distillersr.com.
About CCC
CCC is committed to advancing copyright, enhancing knowledge, and driving innovation through comprehensive and flexible solutions in copyright management and data analytics.
DistillerSR Inc. Media Contact
Chris Wright
(613) 212-0051
Frequently Asked Questions
What is the significance of the DistillerSR and CCC collaboration?
This partnership aims to improve access to scientific literature, enhancing the efficiency of literature reviews for researchers.
How does the integration with RightFind Enterprise benefit users?
It simplifies the ordering process for scholarly articles, allowing users to manage tasks within a single platform without the need to log into multiple systems.
What features does RightFind Enterprise provide?
RightFind Enterprise includes modules that enable searching, sharing, and analyzing scientific content, designed for R&D-focused companies.
How has DistillerSR impacted literature reviews?
DistillerSR has been instrumental in reducing literature review times by as much as 70%, increasing efficiency and transparency in the process.
Who can benefit from using DistillerSR?
Over 260 leading research organizations, including major pharmaceutical and medical device companies, rely on DistillerSR to streamline their literature review processes.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.